0
PharmaMar Banner Image

PharmaMar

  • Ticker
    Exchange
  • Industry Biotechnology More
  • Sector Healthcare More
PharmaMar Logo Image
  • 201-500 Employees
  • Based in Madrid, Spain
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissueMore sarcomas and for ovarian cancer; and Aplidin for treating multiple myeloma. The company also develops clinical-stage programs, including Lurbinectedin, PM184, and PM14. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain.
REPORT RATINGS
4.8 / 5.0 (152)

PharmaMar reports have an aggregate usefulness score of 4.8 based on 152 reviews.

PharmaMar

Most Recent Annual Report

PharmaMar
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

PharmaMar Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!